Heparin coating reduces cell activation and mediator release in an in vitro venovenous bypass model for liver transplantation

Transplant International

Volumn 11, Issue 4, 1998, Pages 252-258

  Solberg, Rigmor ^a   Scholz, Tim ^a   Videm, Vibeke ^b   Okkenhaug, Cecilie ^a   Aasen, Ansgar O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Heparin coating, venovenous bypass, liver transplantation; Leukocyte activation, cytokines, liver transplantation; Liver transplantation, venovenous bypass, heparin coating; Venovenous bypass, heparin coating, liver transplantation

Indexed keywords

CD14 ANTIGEN; CELL ENZYME; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE;

AGAR GEL ELECTROPHORESIS; ARTICLE; BLOOD LEVEL; CELL ACTIVATION; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME RELEASE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LIVER TRANSPLANTATION; MAGNETISM; MEDIATOR RELEASE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VEIN BYPASS; VENOVENOUS SHUNT;

ANTICOAGULANTS; ANTIGENS, CD14; CYTOKINES; HEPARIN; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIVER TRANSPLANTATION; NEUTROPHIL ACTIVATION; PEROXIDASE; PROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 0031879161     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050137     Document Type: Article

References (20)

1. Bazzoni G, Dejana E, Machio A del (1991) Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 76: 491-499
2. Dinarello C (1994) The interleukin-1 family: 10 years of discovery. FASEB J 8: 1314-1325
3. Gerlach J, Jörres A, Berger A, Schön M, Smith MD, Nohr R, Neuhaus P (1996) Systemic liberation of interleukin-1β and interleukin-1 receptor antagonist in the perioperative phase of liver transplantation. Transpl Int 9: 408-414
4. Kirklin JK, Kirklin JW (1990) Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr. Spencer FC (eds) Surgery of the chest. Saunders, Philadelphia, pp 1107-1125
5. Larm O, Larsson R, Olsson P (1983) A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Miomat Med Dev Artif Org 11: 161-173
6. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T (1985) Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82: 6133-6137
7. Neuhaus P, Platz KP (1994) Liver transplantation: newer surgical approaches. Baillieres Clin Gastroenterol 8: 481-493
8. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312: 724-729
9. Redmond JM, Gillinov AM, Stuart RS, Zehr KJ, Winkelstein JA, Herskowitz A, Cameron DE, Baumgartner WA (1993) Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 56: 474-479
10. Riegel W, Spillner G, Schlosser V, Hørl WH (1988) Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 95: 1014-1019
11. Schindler R, Clark BD, Dinarello CA (1990) Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 265: 10232-10237
12. Scholz T, Mathisen Ø, Bergan A, Osnes S, Innes R, Pedersen T, Aasen AO, Søreide O (1997) Percutanous technique for venovenous bypass including a heat exchanger is safe and reliable in liver transplantation. Transpl Int 10: 180-184
13. Segesser LK von, Weiss BM, Garcia E, Gallino A, Turina MI (1990) Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. Eur J Cardiothorac Surg 4: 639-643
14. Seghal PB, Grieninger G, Tosato T (eds) (1989) Regulation of the acute phase and immune responses: interleukin-6. Ann NY Acad Sci 557: 1-583
15. Shaw BJ, Martin DJ, Marquez JM, Kang YG, Bugbee A, Ywatsugy S, Griffith BP, Hardisty RL, Bahnson HT, Starzl TE (1984) Venous bypass in clinical liver transplantation. Ann Surg 200: 524
16. Suzuki S, Toledo-Pereyra LH (1994) Interleukin-1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57: 253-258
17. Ulevitch RJ, Tobias PS (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13: 437-457
18. Venge P, Nilsson L, Nyström SO, Åberg T (1987) Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass. A model to estimate human turnover of lactoferrin and myeloperoxidase. Eur J Haematol 39: 339-345
19. Videm V (1996) Heparin in clinical doses "primes" granulocytes to subsequent activation as measured by myeloperoxidase release. Scand J Immunol 43: 385-390
20. Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE (1992) Reduced complement activation with heparin coated oxygenator and tubings in coronary bypass surgery. J Thorac Cardiovasc Surg. 103: 806-813